REPORTING OF ADVERSE EVENTS. Each party will give prompt notice to the other party of any information it receives regarding the safety of the Product, including any confirmed or unconfirmed information on adverse, serious, or unexpected events associated with the use of the Product (i) by telephone by the end of the next calendar day and (ii) in writing via facsimile within three calendar days after receipt of the information. Pharmion will file any reports concerning such incidents required by law or regulation in the Territory.
Appears in 2 contracts
Sources: License Agreement (Celgene Corp /De/), License Agreement (Pharmion Corp)